Lillian Gaber, MD

Professor of Pathology and Genomic Medicine, Academic Institute
Houston Methodist
Weill Cornell Medical College


Dr. Gaber received her M.D. degree from the Ain Shams University School of Medicine in Cairo, Egypt in 1976. She then completed residencies in anatomical and clinical pathology at the New England Deaconess Hospital in Boston, Massachusetts, and a fellowship in perinatal obstetrics and gynecology pathology at the Brigham and Women’s Hospital. Dr. Gaber joined the faculty at the University of Memphis in Memphis, Tennessee as an assistant professor in the Department of Pathology in 1987. She became a full professor there in 1998. While at the University of Memphis, Dr. Gaber held many leadership positions including director of the Electron Microscopy and Renal Laboratories, director of the General Histology Laboratories, director of the Special Histology Laboratory in the Department of Pathology, and Chief of Clinical Services for the Department of Pathology. Dr. Gaber joined the Department of Pathology and Genomic Medicine at Houston Methodist in 2005 and received her faculty appointment at the Weill Cornell Medical College in 2010.

Description of Research

Dr. Gaber is board certified in anatomic pathology with a subspecialty interest in nephropathology. Her research focuses on studying donor kidney biopsies at the cellular and molecular levels to determine suitability for transplantation, changes following organ reperfusion, and the efficacy of immunosuppressive therapies.

Education & Training

Internship, Washington Hospital Center
MD, Ain Shams University School of Medicine
Clinical Fellowship, Harvard University
Residency, New England Deaconess Hospital

Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity
Tantranont, N, Luque, Y, Hsiao, M, Haute, C, Gaber, L, Barrios, R, Adrogue, HE, Niasse, A & Truong, LD 2021, , Kidney International Reports, vol. 6, no. 7, pp. 1912-1922.

Prevalence, Characteristics, and Outcomes of Incidental IgA Glomerular Deposits in Donor Kidneys
Gaber, LW, Khan, FN, Graviss, EA, Nguyen, DT, Moore, LW, Truong, LD, Barrios, RJ & Suki, WN 2020, , Kidney International Reports, vol. 5, no. 11, pp. 1914-1924.

Prevalence, Characteristics, and Outcomes of Incidental IgA Glomerular Deposits in Donor Kidneys
Gaber, LW, Khan, FN, Graviss, EA, Nguyen, DT, Moore, LW, Truong, LD, Barrios, RJ & Suki, WN 2020, , Kidney International Reports, vol. 5, no. 11, pp. 1914-1924.

A Kidney Transplant Recipient With Coronavirus Disease 2019: Utility of a Prognostication Score
Adrogué, AH, Mithani, F, Ibrahim, HN, Schwartz, MR, Gaber, L, Hebert, SA & Adrogué, HE 2020, , Transplantation Proceedings, vol. 52, no. 9, pp. 2688-2692.

Kidney donors with diabetes: Renal biopsy findings at time of transplantation and their significance
Truong, L, Suki, WN, Gaber, LW, Gaber, AO & Khan, F 2019, , Transplantation Direct, vol. 5, no. 7, e465.

Donor-related diabetic nephropathy: a comprehensive clinicopathological study
Truong, LD, Gaber, LW & Khan, F 2019, , Human Pathology, vol. 85, pp. 136-144.

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
Mamlouk, O, Selamet, U, Machado, S, Abdelrahim, M, Glass, WF, Tchakarov, A, Gaber, L, Lahoti, A, Workeneh, B, Chen, S, Lin, J, Abdel-Wahab, N, Tayar, J, Lu, H, Suarez-Almazor, M, Tannir, N, Yee, C, Diab, A & Abudayyeh, A 2019, , Journal for immunotherapy of cancer, vol. 7, no. 1, 2.

Clinical and pathologic outcomes of incidental IgA glomerular deposits (IgAGD) in donated kidneys in an ethnically diverse region of the USA
Gaber, LW, Khan, F, Barrios, R, Truong, L, Graviss, E, Nguyen, DTM & Suki, W 2018, Transplantation, vol. 102.

Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia
Knight, RJ, Graviss, EA, Nguyen, DT, Kuten, SA, Patel, SJ, Gaber, L & Gaber, AO 2018, , Clinical Transplantation, vol. 32, no. 6, e13265, pp. e13265.

Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes
Modena, BD, Kurian, SM, Gaber, LW, Waalen, J, Su, AI, Gelbart, T, Mondala, TS, Head, SR, Papp, S, Heilman, R, Friedewald, JJ, Flechner, SM, Marsh, CL, Sung, RS, Shidban, H, Chan, L, Abecassis, MM & Salomon, DR 2016, , American Journal of Transplantation, vol. 16, no. 7, pp. 1982-1998.

Simultaneous Scalp, Skull, Kidney, and Pancreas Transplant from a Single Donor
Selber, JC, Chang, EI, Clemens, MW, Gaber, L, Hanasono, MM, Klebuc, M, Skoracki, RJ, Trask, T, Yu, P & Gaber, AO 2016, , Plastic and Reconstructive Surgery, vol. 137, no. 6, pp. 1851-1861.

Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction
Patel, SJ, Suki, WN, Loucks-DeVos, J, Graviss, EA, Nguyen, DT, Knight, RJ, Kuten, SA, Moore, LW, Teeter, LD, Gaber, LW & Gaber, AO 2016, , Transplant International, vol. 29, no. 8, pp. 897-908.

Observations on the use of cidofovir for BK virus infection in renal transplantation
Kuten, SA, Patel, SJ, Knight, RJ, Gaber, LW, Devos, JM & Gaber, AO 2014, , Transplant Infectious Disease, vol. 16, no. 6, pp. 975-983.

Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome
Gupte, AA, Sabek, OM, Fraga, D, Minze, LJ, Nishimoto, SK, Liu, JZ, Afshar, S, Gaber, L, Lyon, CJ, Gaber, AO & Hsueh, WA 2014, , Endocrinology, vol. 155, no. 12, pp. 4697-4705.

Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling
Kurian, SM, Williams, AN, Gelbart, T, Campbell, D, Mondala, TS, Head, SR, Horvath, S, Gaber, L, Thompson, R, Whisenant, T, Lin, W, Langfelder, P, Robison, EH, Schaffer, RL, Fisher, JS, Friedewald, J, Flechner, SM, Chan, LK, Wiseman, AC, Shidban, H, Mendez, R, Heilman, R, Abecassis, MM, Marsh, CL & Salomon, DR 2014, , American Journal of Transplantation, vol. 14, no. 5, pp. 1164-1172.

Tubulointerstitial nephritis in systemic lupus erythematosus: Innocent bystander or ominous presage
Dhingra, S, Qureshi, R, Abdellatif, A, Gaber, L & Truong, L 2014, , Histology and Histopathology, vol. 29, no. 5, pp. 553-565.

A surgeons' guide to renal transplant immunopathology, immunology, and immunosuppression
Gaber, LW, Knight, RJ & Patel, SJ 2013, , Surgical Clinics of North America, vol. 93, no. 6, pp. 1293-1307.

Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy
Knight, RJ, Gaber, LW, Patel, SJ, Devos, JM, Moore, LW & Gaber, AO 2013, , Transplantation, vol. 96, no. 7, pp. e51.

Profound nephrotic syndrome in a patient with ovarian teratoma.
Jeroudi, A, Kadikoy, H, Gaber, L, Ramanathan, V, Frome, A, Anwar, N & Abdellatif, A 2013, , Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, vol. 24, no. 4, pp. 777-782.

Outcomes of living donor renal transplants with a negative cross-match and pretransplant donor-specific antibody
Knight, RJ, Devos, JM, Patel, SJ, Land, G, Moore, LW, Gaber, L & Gaber, AO 2013, , Transplantation Proceedings, vol. 45, no. 4, pp. 1399-1401.